Coston McIsaac & Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Coston McIsaac & Partners's JNJ Position: Q1 2026 in Review
Coston McIsaac & Partners reduced its Johnson & Johnson (JNJ) stake by 4.3% in Q1 2026, selling an estimated $391K and leaving 37,343 shares worth $9.13M. The position accounts for 2.06% of the portfolio, ranked #13.
Coston McIsaac & Partners first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Coston McIsaac & Partners held 37,343 shares of Johnson & Johnson worth $9.13M as of Q1 2026.
- Coston McIsaac & Partners sold 1,679 Johnson & Johnson shares in Q1 2026, an estimated $391K.
- Johnson & Johnson made up 2.06% of Coston McIsaac & Partners's portfolio in Q1 2026, its #13 holding.
- Coston McIsaac & Partners first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
- 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Coston McIsaac & Partners's 13F filing for Q1 2026, filed 22 Apr 2026.